Botox® after Botox® - a new approach to treat diplopia secondary to cosmetic botulinic toxin use: case reports

A new technique for the treatment of diplopia secondary to cosmetic botulinum toxin A use is described. In this interventional case reports, two consecutive patients who developed diplopia after periocular cosmetic use of botulinum toxin A were treated with intramuscular botulinum toxin A injection...

Full description

Bibliographic Details
Main Authors:	Cassiano Rodrigues Isaac, Maria Regina Catai Chalita, Luciana D. Pinto
Format:	Article
Language:	English
Published:	Conselho Brasileiro de Oftalmologia 2012-06-01
Series:	Arquivos Brasileiros de Oftalmologia
Subjects:	Toxinas botulínicas tipo A Estrabismo Diplopia Fármacos neuromusculares Humanos Feminino Adulto Relatos de casos
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27492012000300014&lng=en&tlng=en

id	doaj-1bd89ff4bc164bc18b6afe224919a18b
record_format	Article
spelling	doaj-1bd89ff4bc164bc18b6afe224919a18b2020-11-24T22:50:42ZengConselho Brasileiro de OftalmologiaArquivos Brasileiros de Oftalmologia1678-29252012-06-0175321321410.1590/S0004-27492012000300014S0004-27492012000300014Botox® after Botox® - a new approach to treat diplopia secondary to cosmetic botulinic toxin use: case reportsCassiano Rodrigues IsaacMaria Regina Catai Chalita0Luciana D. PintoUniversidade de BrasíliaA new technique for the treatment of diplopia secondary to cosmetic botulinum toxin A use is described. In this interventional case reports, two consecutive patients who developed diplopia after periocular cosmetic use of botulinum toxin A were treated with intramuscular botulinum toxin A injection into the antagonist extraocular muscle. Diplopia resolved in both patients in less than 1 week with no side effects or complications. In conclusion, the injection of intramuscular botulinum toxin A is an encouraging option for treatment of diplopia secondary to botulinum toxin A use for facial lifting.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27492012000300014&lng=en&tlng=enToxinas botulínicas tipo AEstrabismoDiplopiaFármacos neuromuscularesHumanosFemininoAdultoRelatos de casos
collection	DOAJ
language	English
format	Article
sources	DOAJ
author	Cassiano Rodrigues Isaac Maria Regina Catai Chalita Luciana D. Pinto
spellingShingle	Cassiano Rodrigues Isaac Maria Regina Catai Chalita Luciana D. Pinto Botox® after Botox® - a new approach to treat diplopia secondary to cosmetic botulinic toxin use: case reports Arquivos Brasileiros de Oftalmologia Toxinas botulínicas tipo A Estrabismo Diplopia Fármacos neuromusculares Humanos Feminino Adulto Relatos de casos
author_facet	Cassiano Rodrigues Isaac Maria Regina Catai Chalita Luciana D. Pinto
author_sort	Cassiano Rodrigues Isaac
title	Botox® after Botox® - a new approach to treat diplopia secondary to cosmetic botulinic toxin use: case reports
title_short	Botox® after Botox® - a new approach to treat diplopia secondary to cosmetic botulinic toxin use: case reports
title_full	Botox® after Botox® - a new approach to treat diplopia secondary to cosmetic botulinic toxin use: case reports
title_fullStr	Botox® after Botox® - a new approach to treat diplopia secondary to cosmetic botulinic toxin use: case reports
title_full_unstemmed	Botox® after Botox® - a new approach to treat diplopia secondary to cosmetic botulinic toxin use: case reports
title_sort	botox® after botox® - a new approach to treat diplopia secondary to cosmetic botulinic toxin use: case reports
publisher	Conselho Brasileiro de Oftalmologia
series	Arquivos Brasileiros de Oftalmologia
issn	1678-2925
publishDate	2012-06-01
description	A new technique for the treatment of diplopia secondary to cosmetic botulinum toxin A use is described. In this interventional case reports, two consecutive patients who developed diplopia after periocular cosmetic use of botulinum toxin A were treated with intramuscular botulinum toxin A injection into the antagonist extraocular muscle. Diplopia resolved in both patients in less than 1 week with no side effects or complications. In conclusion, the injection of intramuscular botulinum toxin A is an encouraging option for treatment of diplopia secondary to botulinum toxin A use for facial lifting.
topic	Toxinas botulínicas tipo A Estrabismo Diplopia Fármacos neuromusculares Humanos Feminino Adulto Relatos de casos
url	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27492012000300014&lng=en&tlng=en
work_keys_str_mv	AT cassianorodriguesisaac botoxafterbotoxanewapproachtotreatdiplopiasecondarytocosmeticbotulinictoxinusecasereports AT mariareginacataichalita botoxafterbotoxanewapproachtotreatdiplopiasecondarytocosmeticbotulinictoxinusecasereports AT lucianadpinto botoxafterbotoxanewapproachtotreatdiplopiasecondarytocosmeticbotulinictoxinusecasereports
_version_	1725671681735786496

Botox® after Botox® - a new approach to treat diplopia secondary to cosmetic botulinic toxin use: case reports

Similar Items